16-fluoro-5-androsten-17-one and Acute Lymphoid Leukemia

16-fluoro-5-androsten-17-one has been researched along with Acute Lymphoid Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Haines, DC; Hursting, SD; James, SJ; Miller, BJ; Perkins, SN; Phang, JM	1

Other Studies

1 other study(ies) available for 16-fluoro-5-androsten-17-one and Acute Lymphoid Leukemia

Article	Year
Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16alpha-fluoro-5-androsten-17-one. Carcinogenesis, 1997, Volume: 18, Issue:5 Topics: Androstenes; Animals; Antineoplastic Agents; Body Weight; Dehydroepiandrosterone; Genes, p53; Liver; Longevity; Male; Mice; Mice, Knockout; Nucleotides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis	1997

Article

Year

Chemoprevention of spontaneous tumorigenesis in nullizygous p53-deficient mice by dehydroepiandrosterone and its analog 16alpha-fluoro-5-androsten-17-one.

Carcinogenesis, 1997, Volume: 18, Issue:5

Topics: Androstenes; Animals; Antineoplastic Agents; Body Weight; Dehydroepiandrosterone; Genes, p53; Liver; Longevity; Male; Mice; Mice, Knockout; Nucleotides; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis

1997